Metabolism Laboratory, Department of Endocrinology, School of Medicine and Medical Sciences, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland
Metabolism Laboratory, Department of Endocrinology, School of Medicine and Medical Sciences, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland
Search for other papers by Malachi J McKenna in
Google Scholar
PubMed
Search for other papers by Barbara F Murray in
Google Scholar
PubMed
Search for other papers by Myra O'Keane in
Google Scholar
PubMed
Search for other papers by Mark T Kilbane in
Google Scholar
PubMed
countries to address at-risk groups. The counterfactual of spurious claims about an epidemic of vitamin D deficiency is causing an increase in the prevalence of hypervitaminosis D as a consequence of unnecessarily high intakes in excess of IOM specifications
Regenerative Medicine Institute at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway (NUIG), Galway, Ireland
Search for other papers by Tomás P Griffin in
Google Scholar
PubMed
Search for other papers by Caroline M Joyce in
Google Scholar
PubMed
Search for other papers by Sumaya Alkanderi in
Google Scholar
PubMed
Search for other papers by Liam M Blake in
Google Scholar
PubMed
Search for other papers by Derek T O’Keeffe in
Google Scholar
PubMed
Search for other papers by Delia Bogdanet in
Google Scholar
PubMed
Department of Clinical Biochemistry, SUHCG, GUH, Galway, Ireland
Search for other papers by Md Nahidul Islam in
Google Scholar
PubMed
Lambe Institute for Translational Research, School of Medicine, NUIG, Galway, Ireland
Search for other papers by Michael C Dennedy in
Google Scholar
PubMed
Search for other papers by John E Gillan in
Google Scholar
PubMed
Search for other papers by John J Morrison in
Google Scholar
PubMed
Regenerative Medicine Institute at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway (NUIG), Galway, Ireland
Search for other papers by Timothy O’Brien in
Google Scholar
PubMed
Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK
NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK
Search for other papers by John A Sayer in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Paula M O’Shea in
Google Scholar
PubMed
recently identified a 32-year-old pregnant female (G 1 P 0 ) who presented with symptomatic hypercalcaemia, hypercalciuria, hypervitaminosis D and suppressed intact PTH (iPTH). Symptom onset occurred at 17 weeks of gestation coinciding with trimester 2 of
Search for other papers by Gabriella Oliveira Lima in
Google Scholar
PubMed
Search for other papers by Alex Luiz Menezes da Silva in
Google Scholar
PubMed
Search for other papers by Julianne Elba Cunha Azevedo in
Google Scholar
PubMed
Search for other papers by Chirlene Pinheiro Nascimento in
Google Scholar
PubMed
Search for other papers by Luana Rodrigues Vieira in
Google Scholar
PubMed
Search for other papers by Akira Otake Hamoy in
Google Scholar
PubMed
Search for other papers by Luan Oliveira Ferreira in
Google Scholar
PubMed
Search for other papers by Verônica Regina Lobato Oliveira Bahia in
Google Scholar
PubMed
Search for other papers by Nilton Akio Muto in
Google Scholar
PubMed
Search for other papers by Dielly Catrina Favacho Lopes in
Google Scholar
PubMed
Search for other papers by Moisés Hamoy in
Google Scholar
PubMed
result in a set of consequences related to hypervitaminosis D, with symptoms that may be related hypercalcemia, which, although rare, has been reported more frequently in recent years ( 8 , 12 , 13 , 14 ). The symptoms of vitamin D toxicity (VDT) can
Search for other papers by Jennifer Walsh in
Google Scholar
PubMed
Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Search for other papers by Peter Selby in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
malignancy Less common causes include Thiazide diuretics Familial hypocalciuric hypercalcaemia Non-malignant granulomatous disease Thyrotoxicosis Tertiary hyperparathyroidism Hypervitaminosis D Rhabdomyolysis Lithium Immobilisation
Search for other papers by Nancy Martini in
Google Scholar
PubMed
Search for other papers by Lucas Streckwall in
Google Scholar
PubMed
Search for other papers by Antonio Desmond McCarthy in
Google Scholar
PubMed
not only is associated with low-grade inflammation and risk of atheroma but can also contribute to low bone mass through induction of secondary hyperparathyroidism; hypervitaminosis D is associated with an increase in AC ( 1 , 11 ), whereas vitamin D
St Michael's Hospital, Metabolism Laboratory, School of Medicine and Medical Sciences, Dún Laoghaire, Dublin, Ireland
St Michael's Hospital, Metabolism Laboratory, School of Medicine and Medical Sciences, Dún Laoghaire, Dublin, Ireland
Search for other papers by Malachi J McKenna in
Google Scholar
PubMed
Search for other papers by Barbara F Murray in
Google Scholar
PubMed
substantial safety window between 50 nmol/l (20 ng/ml) and 125 nmol/l (50 ng/ml). There are now five reasons why the Endocrine Society's CPG could lead to either unnecessary overreplacement for many or hypervitaminosis D with potential harm for some: i
Search for other papers by Mohammed S Razzaque in
Google Scholar
PubMed
Fgf23 knockout mice reversed the hypervitaminosis D (from high serum 1,25(OH) 2 D 3 levels to low serum levels) that was consistently noted in fgf23 knockout mice ( 37 ), again providing an in vivo evidence of FGF23 and vitamin D interactions. An
Search for other papers by Barbara J Boucher in
Google Scholar
PubMed
between the protective effects of vitamin K and vitamin A on the modulation of hypervitaminosis D3 short-term toxicity in adult albino rats . Turkish Journal of Medical Sciences 2016 46 524 – 538 . ( https://doi.org/10.3906/sag-1411-6 ) 77 Cheng